BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37722701)

  • 21. A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma: Clinical trial/experimental study.
    Tian J; Yang Y; Li MY; Zhang Y
    Medicine (Baltimore); 2020 Jan; 99(3):e18868. PubMed ID: 32011509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Validation of a Pathomics Model Using Machine Learning to Predict CXCL8 Expression and Prognosis in Head and Neck Cancer.
    Wang W; Ruan S; Xie Y; Fang S; Yang J; Li X; Zhang Y
    Clin Exp Otorhinolaryngol; 2024 Feb; 17(1):85-97. PubMed ID: 38246983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
    Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
    Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?
    Tímár J; Gyorffy B; Rásó E
    Clin Exp Metastasis; 2010 Aug; 27(6):371-87. PubMed ID: 20177751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and Verification of Molecular Subtypes with Enhanced Immune Infiltration Based on m6A Regulators in Cutaneous Melanoma.
    Lin Y; Wang S; Liu S; Lv S; Wang H; Li F
    Biomed Res Int; 2021; 2021():2769689. PubMed ID: 33490266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a Pathomics-Based Model for the Prediction of Malignant Transformation in Oral Leukoplakia.
    Cai X; Li L; Yu F; Guo R; Zhou X; Zhang F; Zhang H; Zhang J; Li T
    Lab Invest; 2023 Aug; 103(8):100173. PubMed ID: 37164265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
    Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
    Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
    Song LB; Luan JC; Zhang QJ; Chen L; Wang HY; Cao XC; Song NH; Lu Y
    J Immunol Res; 2021; 2021():6686284. PubMed ID: 33688507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a predictive gene signature related to pyroptosis for the prognosis of cutaneous melanoma.
    Shi Z; Gu J; Yao Y; Wu Z
    Medicine (Baltimore); 2022 Sep; 101(36):e30564. PubMed ID: 36086707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nomogram based on autophagy related genes for predicting the survival in melanoma.
    Deng G; Wang W; Li Y; Sun H; Chen X; Zeng F
    BMC Cancer; 2021 Nov; 21(1):1258. PubMed ID: 34809598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of diagnostic and prognostic models based on gene signatures of nasopharyngeal carcinoma by machine learning methods.
    Wang Y; He Y; Duan X; Pang H; Zhou P
    Transl Cancer Res; 2023 May; 12(5):1254-1269. PubMed ID: 37304552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of Deep Learning on the Prognosis of Cutaneous Melanoma Based on Full Scan Pathology Images.
    Li A; Li X; Li W; Yu X; Qi M; Li D
    Biomed Res Int; 2022; 2022():4864485. PubMed ID: 36072469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer.
    Chen S; Jiang L; Zheng X; Shao J; Wang T; Zhang E; Gao F; Wang X; Zheng J
    Cancer Sci; 2021 Jul; 112(7):2905-2914. PubMed ID: 33931925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a Four-mRNA Expression-Based Prognostic Signature for Cutaneous Melanoma.
    Bai H; Wang Y; Liu H; Lu J
    Front Genet; 2021; 12():680617. PubMed ID: 34335689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of hub gene and lncRNA signature related to entotic cell death in cutaneous melanoma for prognostic and immune prediction.
    Zhang C; Shen C
    Medicine (Baltimore); 2023 Nov; 102(45):e35881. PubMed ID: 37960805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting Survival for Cutaneous Melanoma.
    Zeng N; Xia Q; Li Y; Ma L; Cheng Y; Chen Y; Lu Q; Lu Z; Wu D; Luo D
    Curr Pharm Des; 2022; 28(28):2349-2361. PubMed ID: 35927923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma.
    Long S; Xu J; Huang H
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer.
    Wang D; Zhang Y; Wang X; Zhang L; Xu S
    Front Genet; 2023; 14():1022265. PubMed ID: 36741321
    [No Abstract]   [Full Text] [Related]  

  • 40. Integrative deep learning analysis improves colon adenocarcinoma patient stratification at risk for mortality.
    Zhou J; Foroughi Pour A; Deirawan H; Daaboul F; Aung TN; Beydoun R; Ahmed FS; Chuang JH
    EBioMedicine; 2023 Aug; 94():104726. PubMed ID: 37499603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.